Characterization of the prostate cancer susceptibility gene KLF6 in human and mouse prostate cancers
- 10 July 2012
- journal article
- research article
- Published by Wiley in The Prostate
- Vol. 73 (2) , 182-193
Abstract
BACKGROUND: Krüppel‐like factor (KLF) 6 is a candidate tumor suppressor gene in prostate cancer, but the mechanisms contributing to its loss of expression are poorly understood. We characterized KLF6 expression and DNA methylation status during prostate tumorigenesis in humans and mice.METHODS: KLF6 expression was assessed in matched human non‐malignant (NM) and tumor prostate tissues (n = 22) by quantitative real‐time PCR (qPCR) and in three independent human prostate cancer cohorts bioinformatically. QPCR for KLF6 expression and methylation‐sensitive PCR (MSP) were performed in human prostate LNCaP cancer cells after 5‐aza‐2′‐deoxycytidine treatment. Klf6 protein levels and DNA promoter methylation were assessed in TRansgenic Adenocarcinoma of Mouse Prostate (TRAMP) tumors by immunohistochemistry and MSP, respectively.RESULTS: KLF6 splice variants expression was increased (P = 0.0015) in human prostate tumors compared to NM tissues. Overall, KLF6 was decreased in metastatic compared to primary prostate cancers and reduced expression in primary tumors was associated with a shorter time to relapse (P = 0.0028). Treatment with the demethylating agent 5‐aza‐2′‐deoxycytidine resulted in up‐regulation of KLF6 expression (two‐fold; P = 0.002) and a decrease in DNA methylation of the KLF6 promoter in LNCaP cells. Klf6 protein levels significantly decreased with progression in the TRAMP model of prostate cancer (P < 0.05), but there was no difference in Klf6 promoter methylation.CONCLUSION: KLF6 expression was decreased in both clinical prostate cancer and the TRAMP model with disease progression, but this could not be explained by DNA methylation of the KLF6 promoter. Prostate 73: 182–193, 2013.Keywords
Funding Information
- National Health and Medical Research Council (627185)
- The Australian Prostate Cancer BioResource by the National Health and Medical Research Council of Australia (290456, 614296)
- Prostate Cancer Foundation of Australia (ID 2011/0452, YI02, YIG03, YI0810, PG2210, EG0809)
- The Cancer Institute NSW Translational Program Grant
- The Hilda Farmer Research Fellowship
- Cancer Council of South Australia Senior Research Fellowship
- W Bruce Hall Cancer Council of South Australia Research Fellowship
- United States Department of Defense Prostate Cancer Research Program Training Fellowship
This publication has 46 references indexed in Scilit:
- Prostate-specific Klf6 Inactivation Impairs Anterior Prostate Branching Morphogenesis through Increased Activation of the Shh PathwayJournal of Biological Chemistry, 2009
- The role of KLF6 and its splice variants in cancer therapyDrug Resistance Updates, 2009
- KLF6 Induces Apoptosis in Prostate Cancer Cells through Up-regulation of ATF3Journal of Biological Chemistry, 2008
- Krüppel-like transcription factors: A functional familyThe International Journal of Biochemistry & Cell Biology, 2008
- Growth Inhibitory Effect of Krueppel-like Factor 6 on Human Prostatic Carcinoma and Renal Carcinoma Cell LinesThe Tohoku Journal of Experimental Medicine, 2008
- Targeted Inhibition of the KLF6 Splice Variant, KLF6 SV1, Suppresses Prostate Cancer Cell Growth and SpreadCancer Research, 2005
- A Germline DNA Polymorphism Enhances Alternative Splicing of the KLF6 Tumor Suppressor Gene and Is Associated with Increased Prostate Cancer RiskCancer Research, 2005
- Cyclin-Dependent Kinase Inhibition by the KLF6 Tumor Suppressor Protein through Interaction with Cyclin D1Cancer Research, 2004
- Krüppel Cripples Prostate CancerThe American Journal of Pathology, 2003
- Krüppel-like Factors: Three Fingers in Many PiesJournal of Biological Chemistry, 2001